test

Oshrat Levi

@Sphera Funds Management Ltd.

Latest period2024 - Q3ReportedManaged Assets$628.383MTotal holdings109
Assets growth rate-14.3%Assets growth rate (2-Q avg)-5.64%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sphera Funds Management Ltd.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 109 positions.

Assets under management

The assets under management (AUM) of Sphera Funds Management Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 628.383M in assets, with a quarterly growth rate of -14.3% and a 2-quarter average growth rate of -5.64%. The portfolio is managed by Oshrat Levi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TEVATeva Pharmaceutical Inds Ltd
Recent Activity
Decreased -47.5%
6.11%
$38.386M
2.13M shares@ $18.02 avg price
SNYSanofi
Recent Activity
Decreased -8.89%
3.76%
$23.6M
409,515 shares@ $57.63 avg price
BBIOBridgebio Pharma Inc
Recent Activity
Decreased -24.4%
3.42%
$21.454M
842,644 shares@ $25.46 avg price
NICENice Ltd
Recent Activity
Decreased -2.72%
3.06%
$19.184M
110,461 shares@ $173.68 avg price
METAMeta Platforms Inc
Recent Activity
Decreased -12.32%
2.68%
$16.782M
29,316 shares@ $572.44 avg price
CYTKCytokinetics Inc
Recent Activity
Decreased -28.55%
2.32%
$14.521M
275,021 shares@ $52.81 avg price
AAPLApple Inc
Recent Activity
Decreased -1.06%
2.26%
$14.177M
60,847 shares@ $233.0 avg price
PRAXPraxis Precision Medicines I
Recent Activity
Decreased -31.83%
2.24%
$14.057M
244,307 shares@ $57.55 avg price
KURAKura Oncology Inc
Recent Activity
Decreased -0.12%
1.9%
$11.921M
610,087 shares@ $19.55 avg price
RAREUltragenyx Pharmaceutical In
Recent Activity
Decreased -33.51%
1.73%
$10.852M
195,349 shares@ $55.56 avg price